Competitor News, Oncology, RWE Study

Exscientia Presents Three Posters Demonstrating Potential of Precision Medicine Platform in Drug Discovery at the American Association of Cancer Research Annual Meeting 2022

Posted on

April 08, 2022 04:01 PM Eastern Daylight Time OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today shared details of its participation at the upcoming American Association for Cancer Research (AACR) Annual Meeting, taking place April 8-13 2022 at the Ernest N. Morial Convention Center in New Orleans, La….

Competitor News, Fundraising/IPO

Clarify Health Closes $150M Series D Funding to Unlock the Promise of Value-Based Care with End-to-End Intelligence on Every Patient Journey

Posted on

April 05, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, announced today that it secured $150 million in Series D financing. SoftBank Vision Fund 2 led the round and was joined by funds and accounts managed by BlackRock and Memorial Hermann Health System, along…

Competitor News, RWE Study

Real-world Data Show Benefits of Increased Lung Cancer Screening but Persistent Disparities

Posted on

New research published in The BMJ indicates the introduction of low dose CT (LDCT) screening in 2013 coincided with improved survival and a shift toward diagnoses of stage I non–small cell lung cancer (NSCLC). However, data also showed disparities in stage diagnoses persist between patient populations and increased efforts to improve access…

Competitor News, Pharma, RWE Study

Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology

Posted on

Sickle Cell Patients Treated With Endari® had Statistically Significantly Fewer Vaso-Occlusive Events and Hospitalizations Through 72 Weeks Follow-up, Versus Baseline Adverse Events Among These Patients from French Guiana and Qatar were Few and Mild TORRANCE, Calif., April 7, 2022 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today…

Ethics, Industry News

UK pharmaceutical industry seeks to establish health data principles amid plans to unlock NHS data

Posted on

The UK’s Association of the British Pharmaceutical Industry (ABPI) has recently concluded a consultation on its new draft industry governance principles aimed at guiding the pharmaceutical industry when analysing and using health data. Recognising the ‘enormous potential’ in unlocking data, which is routinely collected and stored by the NHS, ‘on everything from…

Collaborations, Competitor News, Data Partnership, Pharma, RWE Study

Foundation Medicine and Collaborators to Share Scientific Advances at AACR22 Reinforcing the Power of Genomic Testing in Precision Cancer Care

Posted on

New studies demonstrate the ability of Foundation Medicine’s portfolio of tests to improve treatment options for patients, and reinforce the company’s role as an essential partner to researchers April 05, 2022 07:05 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that the company and its collaborators will…